Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
Chung‐Yi Wu, Cheng‐Wei Cheng, Chih‐Chuan Kung, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Sachin S. Shivatare, Vidya S. Shivatare, Chi‐Huey Wong
Chemical Reviews (2022) Vol. 122, Iss. 20, pp. 15603-15671
Open Access | Times Cited: 103
Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models
Han-Yi Huang, Hsin-Yu Liao, Xiaorui Chen, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 639
Open Access | Times Cited: 99
Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines
Liyan Guo, Sheng Lin, Zimin Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44
PEDV-spike-protein-expressing mRNA vaccine protects piglets against PEDV challenge
Yongxiang Zhao, Baochao Fan, Xu Song, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 19
Variations within the Glycan Shield of SARS-CoV-2 Impact Viral Spike Dynamics
Maddy L. Newby, Carl A. Fogarty, Joel D. Allen, et al.
Journal of Molecular Biology (2022) Vol. 435, Iss. 4, pp. 167928-167928
Open Access | Times Cited: 44
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Kinetics of RNA-LNP delivery and protein expression
Judith Müller, Nathalie Gabriele Schäffler, Thomas Kellerer, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 197, pp. 114222-114222
Open Access | Times Cited: 8
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 214-226
Open Access | Times Cited: 8
mRNA vaccines in the prevention and treatment of diseases
Yangzhuo Gu, Jiangyao Duan, Na Yang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Nanoparticles in clinical trials of COVID-19: An update
Abdur Rauf, Tareq Abu‐Izneid, Anees Ahmed Khalil, et al.
International Journal of Surgery (2022) Vol. 104, pp. 106818-106818
Open Access | Times Cited: 32
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies
Frances Rocamora, Angelo G. Peralta, Seunghyeon Shin, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108206-108206
Open Access | Times Cited: 20
mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious Diseases
Saeideh Khorshid Sokhangouy, Mohammad Amin Behzadi, Samira Rezaei, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 2
Closed Access
Changes in the motifs in the D0 and SD2 domains of the S protein drive the evolution of virulence in enteric coronavirus porcine epidemic diarrhea virus
Zhiqian Ma, Zhiwei Li, Yongqi Li, et al.
Journal of Virology (2025)
Open Access
Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19
Yu Wen, Ruyan Zhang, Jian Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 238-247
Open Access | Times Cited: 15
Lignocellulosic biomass-based glycoconjugates for diverse biotechnological applications
Cristiano E. Rodrigues Reis, Thais S. Milessi, Márcio Daniel Nicodemos Ramos, et al.
Biotechnology Advances (2023) Vol. 68, pp. 108209-108209
Closed Access | Times Cited: 12
Transient Expression of Glycosylated SARS-CoV-2 Antigens in Nicotiana benthamiana
Valentina Ruocco, Richard Strasser
Plants (2022) Vol. 11, Iss. 8, pp. 1093-1093
Open Access | Times Cited: 18
Evolving spike-proteinN-glycosylation in SARS-CoV-2 variants
Sabyasachi Baboo, Jolene K. Diedrich, Jonathan L. Torres, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 11
Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants
Sabrina Lusvarghi, Charles B. Stauft, Russell Vassell, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011788-e1011788
Open Access | Times Cited: 9
Vaccines against SARS-CoV-2 variants and future pandemics
Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1363-1376
Open Access | Times Cited: 15
Adjuvant-Free COVID-19 Vaccine with Glycoprotein Antigen Oxidized by Periodate Rapidly Elicits Potent Immune Responses
Ruyan Zhang, Shihao Zhou, Ran-Ran Feng, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 4, pp. 915-923
Closed Access | Times Cited: 8
Modulation of endoplasmic reticulum stress response pathways by respiratory viruses
Kyle L. Macauslane, Cassandra L. Pegg, Kirsty R. Short, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 5, pp. 750-768
Closed Access | Times Cited: 8
In vivo deglycosylation of recombinant glycoproteins in tobacco BY‐2 cells
Xavier Herman, Johann Far, Marie Peeters, et al.
Plant Biotechnology Journal (2023) Vol. 21, Iss. 9, pp. 1773-1784
Open Access | Times Cited: 7
SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC)
Spyros Charonis, Lisa M. James, Apostolos P. Georgopoulos
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Glycovaccinology: The design and engineering of carbohydrate-based vaccine components
Sophia W. Hulbert, Primit Desai, Michael C. Jewett, et al.
Biotechnology Advances (2023) Vol. 68, pp. 108234-108234
Open Access | Times Cited: 6
Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA)
Cheng‐Wei Cheng, Chung‐Yi Wu, Szu‐Wen Wang, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 49
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top